Skip to main content

John Orwin

Equibles does not estimate personal net worth.

Get an email with a short summary when Anaptysbio, Inc publishes a filing, an earnings call transcript or a press release.

Get ANAB alerts

About John Orwin

John Orwin is recorded as Chairman and Board Member at Anaptysbio, Inc (ANAB). The newest filing on record that lists John Orwin as Board Member at Anaptysbio, Inc (ANAB) is dated June 29, 2026. The newest filing on record that lists John Orwin as Chairman at Anaptysbio, Inc (ANAB) is dated April 29, 2025. Anaptysbio, Inc reported in an 8-K filed March 27, 2026 that John Orwin was appointed Board of Directors. Anaptysbio, Inc reported in an 8-K filed September 18, 2023 that John Orwin was appointed Chairman of the Board, effective September 15, 2023. Anaptysbio, Inc reported in an 8-K filed September 18, 2023 that John Orwin was appointed Class II director, effective September 15, 2023. Anaptysbio, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Anaptysbio, Inc includes Daniel Faga (CEO and Board Member), Ajim Tamboli (CFO), Christopher M. Murphy (CFO) and 7 others.

“• | Board of Directors will include certain current members of Anaptys’ Board: Daniel Faga; Dennis Fenton,Ph.D.; John Orwin (Chairman); John Schmid; Magda Marquet, Ph.D.; Rita Jain, M.D.; and Tony Ware, M.D. |”
Anaptysbio, Inc Form 8-K, filed March 27, 2026 · Read the filing
“On September 15, 2023, the Board appointed John Orwin as a Class II director, a member of the Nominating and Corporate Governance Committee and Chairman of the Board, effective immediately.”
Anaptysbio, Inc Form 8-K, filed September 18, 2023 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Chairman, Board Member

Leadership on record at Anaptysbio, Inc

Recent activity